Medicofarma Biotech Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '26 Jul 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	28	26	74	79	116	20
Market Cap Growth	23.03%	-64.24%	-6.06%	-32.06%	482.19%	848.05%
Enterprise Value	31.51	28.9	75.14	78.01	115.49	19.79
Last Close Price	0.41	0.39	1.09	1.16	1.70	2.92
PS Ratio	628.68	21.53	98.24	18.46	34.63	5.44
PB Ratio	5.40	3.84	8.04	6.22	8.14	-86.80
P/TBV Ratio	5.44	3.89	8.17	7.09	9.46	-
P/OCF Ratio	-	-	10164.50	81.76	63.65	-
EV/Sales Ratio	-	23.59	100.08	18.34	34.61	5.42
EV/EBITDA Ratio	-	-	-	453.88	157.59	-
Debt / Equity Ratio	0.77	0.37	0.15	0	0	0
Net Debt / Equity Ratio	0.77	0.37	0.15	-0.04	0.00	0.28
Net Debt / EBITDA Ratio	-	-4.80	-0.93	-2.95	-0.11	0.12
Net Debt / FCF Ratio	-	-2.48	-1.26	2.05	0.16	0.21
Asset Turnover	-	0.08	0.05	0.26	0.39	4.09
Inventory Turnover	-	1717.76	46.11	16.68	10.44	16.87
Quick Ratio	0.13	0.20	0.21	0.49	0.90	0.34
Current Ratio	1.08	1.21	1.37	1.02	1.23	0.62
Return on Equity (ROE)	-	-28.67%	-31.57%	-11.85%	-3.08%	-399.46%
Return on Assets (ROA)	-	-13.84%	-20.87%	-9.52%	-2.54%	-68.31%
Return on Invested Capital (ROIC)	-	-20.58%	-28.86%	-12.02%	-3.14%	-263.90%
Return on Capital Employed (ROCE)	-	-16.81%	-25.47%	-10.79%	-2.94%	-249.74%
Buyback Yield / Dilution	-	0.00%	0.00%	0.00%	-900.00%	0.00%
Total Shareholder Return	-	0.00%	0.00%	0.00%	-900.00%	0.00%